{"id":"W2736055518","doi":"10.2174/1389450118666170711151518","title":"PARP Inhibitor Drugs in the Treatment of Breast, Ovarian, Prostate and Pancreatic Cancers: An Update of Clinical Trials","year":2018,"lang":"en","type":"review","venue":"Current Drug Targets","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University","funders":"","keywords":"Olaparib; PARP inhibitor; Medicine; Ovarian cancer; Prostate cancer; Pancreatic cancer; Breast cancer; Clinical trial; Oncology; Cancer; Internal medicine; Cancer research; Poly ADP ribose polymerase; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005247519,0.000608954,0.005500408,0.0002749499,0.00004687692,0.00002112041,0.0002424873,0.0002414341,0.0001197184],"category_scores_gemma":[0.0002283575,0.0003459262,0.0008781891,0.0004022793,0.000493404,0.0001040532,0.00003299501,0.0003933469,0.00001364255],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003096712,"about_ca_system_score_gemma":0.001354726,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001184897,"about_ca_topic_score_gemma":0.00002393275,"domain_scores_codex":[0.9915229,0.003082256,0.003748507,0.0007393528,0.0005201395,0.0003868107],"domain_scores_gemma":[0.9950047,0.001199598,0.002434479,0.0009258591,0.0002052562,0.0002300818],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006484275,0.001546902,0.0005396006,0.01114404,0.0005205213,0.000009189639,0.003093123,1.834795e-7,0.000001102016,0.00003862034,0.003892738,0.9785656],"study_design_scores_gemma":[0.006310442,0.001036921,0.0002192694,0.025576,0.002553127,0.00004764797,0.0001774654,0.00001250291,0.00003430112,0.0002092771,0.9634901,0.0003329196],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005218402,0.987606,0.000006279094,0.000171771,0.001405572,0.004279759,0.001228801,0.00002297482,0.00006037176],"genre_scores_gemma":[0.0009629571,0.9954154,0.0001837301,0.00003880776,0.001910233,0.0007441632,0.0006394966,0.00006074956,0.00004443813],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9782326,"threshold_uncertainty_score":0.9998993,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2069710424431445,"score_gpt":0.5032244185833384,"score_spread":0.2962533761401939,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}